Advertisement

Topics

Demegen Incorporated Company Profile

16:51 EST 19th November 2017 | BioPortfolio

Demegen’s headquarters is in Pittsburgh, Pennsylvania, with additional offices and laboratories near Boston, Massachusetts. The Company has nine full and part-time employees. Demegen has been a public company since it was founded in July 1992. The Company’s lead products address important unmet medical needs. The clinical trials for initial target disease indications generally address acute symptoms and therefore are easier to manage. The Company holds twenty-eight issued patents, including composition of matter protection on over fifty compounds. Four lead compounds are under active development, primarily for topical bacterial and fungal infections. Demegen plans to obtain co-development partners for specific product applications in order to reduce development cost but maintain concurrent development of multiple products.

While Demegen maintains research laboratories for core activities, it minimizes infrastructure costs by outsourcing toxicology and in vivo efficacy studies and collaborating with university and government researchers. These relationships enable Demegen to create more value from its platform technologies and allow the Company to efficiently diffuse risks.

Location

1051 Brinton Road
Pittsburgh
PA
15221
United States of America

Contact

Phone: 412 241 2150
Fax: 412 241 2161


News Articles [1 Associated News Articles listed on BioPortfolio]

Vical Incorporated Announces Pricing of $25 Million Underwritten Public Offering of Common Stock

SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [38 Associated Companies listed on BioPortfolio]

Demegen Incorporated

Demegen’s headquarters is in Pittsburgh, Pennsylvania, with additional offices and laboratories near Boston, Massachusetts. The Company has nine full and part-time employees. Demegen has been a pu...

Demegen

Demegen develops natural and novel peptides for the treatment or prevention of infections due to multi-drug resistant bacteria and fungi. The Company's lead products address important unmet medical ne...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

COOK BIOTECH INCORPORATED

COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...

More Information about "Demegen Incorporated" on BioPortfolio

We have published hundreds of Demegen Incorporated news stories on BioPortfolio along with dozens of Demegen Incorporated Clinical Trials and PubMed Articles about Demegen Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Demegen Incorporated Companies in our database. You can also find out about relevant Demegen Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record